ALKBH5 and renal cell carcinoma: Taken together, our data indicated that elevated levels of the m6A demethylase ALKBH5 in renal cell carcinoma may lead to increased expression of downstream MANF, activating tumor cell UPR, and resulting in cells proliferation and invasion.